| Mission Point Nsg & Phy Rehab Ctr Of Clinton Twp | |
| 17001 17 Mile Rd, Clinton Township, Michigan 48038 | |
| (248) 940-5390 | |
| Name | Mission Point Nsg & Phy Rehab Ctr Of Clinton Twp |
|---|---|
| Location | 17001 17 Mile Rd, Clinton Township, Michigan |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 127 |
| Occupancy Rate | 84.41% |
| Medicare ID (CCN) | 235405 |
| Legal Business Name | Legal Business Name Not Available |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1619566098 |
| Organization Name | MISSION POINT OF CLINTON TOWNSHIP LLC |
| Doing Business As | MISSION POINT NURSING & PHYSICAL REHABILITATION CENTER OF CLINTON TWP |
| Address | 17001 17 Mile Rd, Clinton Township, MI 48038 |
| Phone Number | 586-286-7100 |
News Archive
Osiris Therapeutics, Inc. today announced that it has achieved a $750,000 milestone payment from the Juvenile Diabetes Research Foundation (JDRF) for completing enrollment in a Phase II clinical trial evaluating Prochymal, an adult mesenchymal stem cell (MSC) therapy, as a treatment for patients recently diagnosed with type 1 diabetes. The milestone is the fourth in a series of payments resulting from JDRF's partnership with Osiris for the development of a therapy for type 1 diabetes.
Scientists from Nanyang Technological University and Lund University, Sweden, have bioengineered a novel molecule which has been proven to successfully kill tumour cells.
Federal and Kaiser Permanente researchers combing the health records of 6.2 million patients found no serious health effects that could be linked to the 2 mRNA COVID-19 vaccines.
In general, I recommend that my patients include nutrient-rich foods such as fruits and vegetables as part of a healthy diet.
› Verified 9 days ago
| NPI Number | 1679516819 |
| Organization Name | SSC CLINTON TOWNSHIP OPERATING COMPANY LLC |
| Doing Business As | CLINTON-AIRE HEALTHCARE CENTER |
| Address | 17001 17 Mile Rd, Clinton Township, MI 48038 |
| Phone Number | 586-286-7100 |
News Archive
Osiris Therapeutics, Inc. today announced that it has achieved a $750,000 milestone payment from the Juvenile Diabetes Research Foundation (JDRF) for completing enrollment in a Phase II clinical trial evaluating Prochymal, an adult mesenchymal stem cell (MSC) therapy, as a treatment for patients recently diagnosed with type 1 diabetes. The milestone is the fourth in a series of payments resulting from JDRF's partnership with Osiris for the development of a therapy for type 1 diabetes.
Scientists from Nanyang Technological University and Lund University, Sweden, have bioengineered a novel molecule which has been proven to successfully kill tumour cells.
Federal and Kaiser Permanente researchers combing the health records of 6.2 million patients found no serious health effects that could be linked to the 2 mRNA COVID-19 vaccines.
In general, I recommend that my patients include nutrient-rich foods such as fruits and vegetables as part of a healthy diet.
› Verified 9 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Osiris Therapeutics, Inc. today announced that it has achieved a $750,000 milestone payment from the Juvenile Diabetes Research Foundation (JDRF) for completing enrollment in a Phase II clinical trial evaluating Prochymal, an adult mesenchymal stem cell (MSC) therapy, as a treatment for patients recently diagnosed with type 1 diabetes. The milestone is the fourth in a series of payments resulting from JDRF's partnership with Osiris for the development of a therapy for type 1 diabetes.
Scientists from Nanyang Technological University and Lund University, Sweden, have bioengineered a novel molecule which has been proven to successfully kill tumour cells.
Federal and Kaiser Permanente researchers combing the health records of 6.2 million patients found no serious health effects that could be linked to the 2 mRNA COVID-19 vaccines.
In general, I recommend that my patients include nutrient-rich foods such as fruits and vegetables as part of a healthy diet.
› Verified 9 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 12.79 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 5.45 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 47.94 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.7 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.02 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.06 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.23 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 74.01 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 10.94 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 13.65 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.31 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 27.39 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 16.67 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 9.93 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 90.96 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 71.25 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 36.91 | 82.93 |
News Archive
Osiris Therapeutics, Inc. today announced that it has achieved a $750,000 milestone payment from the Juvenile Diabetes Research Foundation (JDRF) for completing enrollment in a Phase II clinical trial evaluating Prochymal, an adult mesenchymal stem cell (MSC) therapy, as a treatment for patients recently diagnosed with type 1 diabetes. The milestone is the fourth in a series of payments resulting from JDRF's partnership with Osiris for the development of a therapy for type 1 diabetes.
Scientists from Nanyang Technological University and Lund University, Sweden, have bioengineered a novel molecule which has been proven to successfully kill tumour cells.
Federal and Kaiser Permanente researchers combing the health records of 6.2 million patients found no serious health effects that could be linked to the 2 mRNA COVID-19 vaccines.
In general, I recommend that my patients include nutrient-rich foods such as fruits and vegetables as part of a healthy diet.
› Verified 9 days ago
Mission Point Nsg & Phy Rehab Ctr Of Clinton Twp Location: 17001 17 Mile Rd, Clinton Township, Michigan 48038 Phone: (248) 940-5390 | |
Lakepointe Senior Care And Rehab Center, L L C Location: 37700 Harper Avenue, Clinton Township, Michigan 48036 Phone: (586) 468-0827 | |
Church Of Christ Care Center Location: 23575 15 Mile Rd, Clinton Township, Michigan 48035 Phone: (586) 791-2470 |